Mazin Sadik, DPM
Podiatrist · Burlington, MANPI 1366930570
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Stryker at 39.1% of the total.
Across 27 payments — averaging $173.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Liberty Surgical Inc.$1K
- Supreme Orthopedic Systems, LLC$1K
- Medical Device Business Services, Inc.$337
- Organogenesis Inc.$69
- Zimmer Biomet$27
- plus $25 from 2 others
What the payments were for
- Travel & lodging$75016%
- Food & beverage$1,20226%
- Education$2,73758%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 19 | $1,832 |
| Liberty Surgical Inc. | 1 | $1,200 |
| Supreme Orthopedic Systems, LLC | 1 | $1,200 |
| Medical Device Business Services, Inc. | 2 | $337 |
| Organogenesis Inc. | 1 | $69 |
| Zimmer Biomet | 1 | $27 |
| Smith+Nephew | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$854
- FLOWTRIEVER CATHETER, S$854
- MICA$215
- ORTHOLOC$150
- PROLAYER$129
- BIO4$129
- ANCHORAGE$111
How this compares
$4,689 in reported general payments places this provider in the 85th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 33 | $1,506 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 51 | $1,134 |
| Ciprofloxacin Hcl | 21 | $196 |
| Meloxicam | 59 | $172 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $108 |
| Gabapentin | 13 | $72 |
| NystopNystatin | 12 | $66 |
| Terbinafine Hcl | 11 | $60 |
| Cefadroxil | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Burlington
- Deepa JhaveriBurlington$5K
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
- Sara Rose-SauldWaltham$92K
- Jonathan KaplanWellesley$56K
- Thanh DinhBoston$48K
- Melissa RicciMilton$46K
- Jeffrey PantanoMilton$46K
- Barry RosenblumBoston$43K
- Louis DecaroWest Hatfield$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.